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Abstract
Aims—To examine whether smoking habits, nicotine dependence (ND) and plasma cotinine
levels differ by diurnal type.
Design—Data originated from the national FINRISK 2007 survey. Regression analyses were
calculated to examine the association between diurnal type and smoking status, ND, and nicotine
intake.
Participants—7091 FINRISK participants with smoking and diurnal type information and a
subset of 1746 ever smokers with detailed smoking, and ND assessments.
Measurements—Diurnal type assessed with a six-item sum scale was categorized as morning,
intermediate and evening type. Smoking status was determined as current (daily or occasional),
former, and never smokers. ND was measured with the Fagerström Test for Nicotine Dependence
(FTND), the Hooked on Nicotine Checklist (HONC), and the Nicotine Dependence Syndrome
Scale (NDSS). For current smokers, plasma cotinine was analyzed as biochemical measurement of
nicotine intake.
Findings—Evening type was associated with current smoking (OR=1.66, 95% CI 1.40, 1.97). A
significant association with diurnal type was seen for FTND among men (beta= -0.46, 95% CI
-0.72, -0.21), sexes combined for HONC (beta= -0.31, 95% CI -0.52, -0.11) and NDSS (beta=
-0.86, 95% CI -1.43, -0.29) and for cotinine among men (beta= -0.73, 95% CI -1.16, -0.29).
Adjustment for depressive symptoms attenuated the association of diurnal type with NDSS to be
non-significant.
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Conclusions—Diurnal type was associated with multiple ND measures and nicotine intake,
interestingly more so among men. Evening type persons are at higher risk of dependence, but
depressive symptoms attenuates this association clearly.
Keywords
Adults; Smoking; Nicotine dependence; Diurnal type; Chronotype; Eveningness; Fagerström test
for nicotine dependence; Nicotine dependence syndrome scale; Hooked on nicotine checklist;
Cotinine
Introduction
People have different sleeping rhythms, diurnal types, which have been shown to be
associated with different health and behavioral risk factors. Diurnal type or chronotype
refers to relatively stable trait-like interindividual differences in temporal organization of
individuals sleep/wake behavior and other physiological functions [1]. The notion can be
seen as a continuum between two extreme types: morning and evening type. In nationwide
Finnish Twin Cohort of adult twins [2] most adults were intermediate types, with about 27%
being morning types and 10% evening types.
Earlier studies, mostly with relatively small sample sizes, have demonstrated an association
between diurnal type and smoking, such as among university students in Japan [3], 14 to 94
year olds in Germany and Austria [4], Hungarian adolescents [5], as well as Finnish
adolescents [6] and adults [7]. These are in line with our recent study of Finnish twins [7]
indicating that by using a single question on diurnal type, the Fagerström Test for Nicotine
Dependence (FTND) [8] and DSM-IV (Diagnostic and Statistical Manual of Mental
Disorders) diagnosis of nicotine dependence (ND) [9] the evening type was strongly
associated with not only being a smoker but also with ND. These associations persisted even
after potential confounders associated with diurnal type and smoking such as mood and
alcohol use [10-13] were taken into account.
The association of smoking and evening type could be explained by genetic and
environmental factors involved in the dopamine and/or opioid systems. These are the key
elements in feelings of pleasure and also in development of addiction. Moreover, it is known
that people with attention deficit hyperactivity disorder are mainly evening types and more
prone to develop addictions than others [14]. Gender differences in the association between
diurnal type and smoking have been found so that risk of current smoking among evening
types was higher among women compared to men [7]. One potential reason might be the
faster nicotine metabolism of women compared to men [15].
Nicotine is a psychoactive stimulant, and there may be some association between this
stimulant effect and the phase of circadian rhythms. Nicotine is a direct agonist of nicotinic
acetylcholine receptors (nAChR) and activates mesolimbic dopaminergic pathways [16,17].
Melatonin levels are associated with chronotype. Dim light melatonin onset, but not sleep
onset nor melatonin offset times, has been shown to be related to chronotype [18]. In
addition, it is shown that melatonin serum concentrations are lower in regular smokers [19].
Melatonin may modulate the effects of nicotine, because melatonin treatment in humans
reduces withdrawal-induced craving among those who have stopped smoking but continue
to suffer the effects of withdrawal [20]. Our hypothesis was that evening type is associated
with higher nicotine dependence according to different ND measurements and nicotine
intake level. Our aim was to replicate and extend earlier published associations concerning
diurnal type and smoking by applying multiple measures of ND and level of nicotine intake.
Using data from the population based National FINRISK 2007 Study we examined whether
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smoking habits, ND measured by the FTND, the Hooked on Nicotine Checklist (HONC)
[21] and the Nicotine Dependence Syndrome Scale (NDSS) [22] as well as plasma cotinine
levels differ by diurnal type assessed by six items.
Methods
Participants
In 2007 the cross sectional FINRISK data and its subsample DILGOM data were collected.
The FINRISK data include a representative sample targeting 11,953 individuals (67%
participation rate) (aged 25 to 74 years) from six different regions of Finland [23] with 7993
participants. Thus 33% (n=3960) of the sample did not return the questionnaire and/or take a
part of clinical examination. The FINRISK data collection includes a questionnaire and a
clinical health examination. From each region, i.e. (1) Helsinki and Vantaa (the metropolitan
area), (2) Turku and Loimaa, (3) Northern Savo, (4) North Karelia, (5) Oulu, and (6)
Lapland participants were invited to fill in the questionnaire (regions # 1-6) and asked to
participate into a locally organized health examination (regions # 1-5) including a blood
sample. Data collection was conducted from January to March 2007. Number of participants
with smoking information was 7883 (3682 men, 47%) and diurnal type information was
provided by 7091 persons, comprising the final number used in the analyses.
Participants of the DILGOM study, a FINRISK sub-sample were identified based on their
responses to the FINRISK smoking questions. In three aforementioned regions (# 1-3)
individuals who answered positively to the question “Have you ever smoked at least 100
cigarettes during your lifetime?” were selected, including daily, occasional and former
smokers. In two regions (# 4-5) those who answered positively to the question “Are you a
current smoker?” were selected, including daily and occasional smokers. These ever
smokers (n=1922) received a questionnaire with detailed smoking and ND assessments
while they visited the DILGOM survey site. This procedure took place from April to June
2007. Participants returned the completed questionnaires by mail and one round of reminder
questionnaires was mailed to non-respondents in November 2007. Total of 1746 ever
smokers participated (91%), comprising the final number used in the analyses.
The FINRISK 2007 study (20.2.2007/229/E0/06) has been approved by the Coordinating
Ethics Committee (Institutional Review Board) of the Hospital District of Helsinki and
Uusimaa.
Assessment
Diurnal type was assessed with six questions derived from the original, biologically verified
Horne-Östberg Morningness-Eveningness Questionnaire (MEQ) of 19 items [24] and whose
sum score correlates with the intrinsic circadian period, demonstrating that a basic property
of the circadian pacemaker associates with this behavioral trait [25,26]. Questions included
items on the most pleasant period of the day to work and to do hard physical task or sport
exercise, the easiness to wake up in the morning, how tired one feels after awakening in the
morning, and how to rate oneself as early bird (morning type) or night owl (evening type).
Since the circadian preference in the present study was assessed with a modified
questionnaire, the psychometric properties were tested. Six items of the original MEQ were
selected on the basis of regression analysis of the items that correlated best with the sum
[11], with which 83% of the variation in the sum was explained. Internal consistency of the
six item scale (Cronbach α=0.78) was adequate. In this study the scored sum scale ranged
from 5 (evening type) to 27 (morning type) and the mean was 17.8 (SD 4.2). The sum score
(low score indicating eveningness) on the scale was divided into three categories, including
the evening (category 3) (definite/moderate) (5-12 points), intermediate (category 2) (13-18
Broms et al. Page 3
J Addict Res Ther. Author manuscript; available in PMC 2012 August 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
points), and morning (category 1, reference group) (definite/moderate) (19-27 points)
chronotypes. This categorization converts the original five-point Morningness-Eveningness
scale [24] into a three-point scale and retains the corresponding ranges for chronotypes.
Smoking status was assessed in FINRISK data by three questions: “Have you ever smoked
regularly, almost every day for at least a year?”, “Do you smoke now?” and “When was the
last time you smoked?” providing categories of daily smokers (smoked today or at least
yesterday), occasional smokers (smoked two days to a month ago), former smokers (quit one
month ago or earlier), and never smokers (never smoked regularly). In the analysis two
classifications of smoking were used. First the category of “current smokers” included daily
and occasional smokers whereas “non-smokers” included former and never smokers.
Secondly “ever smokers” included current and former smokers, while “never smokers” were
those who had never smoked regularly. Cigarettes per day variable included the sum of both
manufactured and self-rolled cigarettes asked by two open-ended questions “How much on
average per day do you smoke or did you smoke before you quit?”.
Measurements of ND included the six-item FTND scale [8] (ranging from 0 to 10), the 10-
item HONC (from 0 to 10) [21], and the 14-item NDSS (from 0 to 56) [22]. Higher scores
mean greater ND in all three scales. Each sum score was used as dependent continuous
variable.
For 645 current smokers belonging to the DILGOM subsample cotinine from blood samples
taken during the clinical examination was used as biochemical measurement of nicotine
metabolites. Cotinine was analysed with a gas chromatograph-mass spectrometer (GC-MS).
(-)-Cotinine was purchased from Sigma-Aldrich (Steinheim, Germany) and cotinine methyl-
D3 (internal standard, IS) from Toronto Research Chemicals (Toronto, Canada).
The frozen plasma samples were thawed over night at +5°C. Cotinine was extracted from
0.5 ml aliquots of the samples with Oasis® MCX 3 cc (Waters; New Bedford, MA, USA)
solid phase extraction cartridges as follows: the cartridges were first conditioned with 1 ml
of methanol and 1 ml of purified water, and then samples were loaded on the cartridges with
2.5 ml of 0.3 M NaH2PO4 buffer containing the IS. Cartridges were washed with 1 ml of
purified water and 1 ml of acetonitrile, dried for 1.5 min, and eluted with 3-% NH3 into test
tubes containing Na2SO4. The eluates were transferred to clean test tubes and evaporated to
dryness with a vacuum evaporator. After dissolving the residues in 60 μl of butyl acetate, 15
μl of the derivatization reagent, N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) was
added. Then, a 2-μl aliquot of the sample was injected into a gas GC-MS.
The analysis was performed with a Hewlett-Packard (Hewlett-Packard Company, Palo Alto,
CA, USA) GC-MS (EI, positive ions, 70 eV). The GC column was a DB-17 ms of length 20
m, internal diameter 0.18 mm and film thickness 0.18 μm (J&W Scientific Inc., Folsom,
CA, USA). Helium was used as the carrier gas. The column temperature was initially 120°C
with a hold time of 3 min, and was increased 45°C/min to 300°C. MS detection was
performed in selected ion monitoring (SIM) mode.
The lower limit of quantitation was set at 5.0 μg/L. Intermediate precision (relative standard
deviation, RSD %) was 3% and accuracy (bias %) was 4% at the concentration level of 100
μg/L. At the lower limit of quantitation the corresponding values were 7% and -2.3%,
respectively.
Participants invited to the clinical examination were told to fast but were not asked to
abstain from smoking before the examination [27]. The time since the last cigarette was
asked from all by the study nurse: “Have you smoked in one hour before the clinical
examination?”. Four percent (3.7%) of 645 current smokers reported that they had smoked
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within one hour before clinical examination. Clinical examinations took place between
10:55 a.m. and 8:10 p.m., with the mean time of the clinical examination being 2:50 p.m.
with no significant difference between chronotypes.
Potential confounders controlled in this study were alcohol use and depressive symptoms
[10,13]. Alcohol use was assessed using the last week’s recall on alcohol consumption and
calculated as grams per week (continuous variable). Depressive symptoms were measured
with having a positive response to the two screening items of depression: the presence of
depressed mood and/or the presence of anhedonia and lack of pleasure at least for two weeks
during past year (variable of three categories) [28,29].
Statistical analyses
Logistic regression analysis was used to examine the association between diurnal type
categories (independent) and smoking status (dependent). Linear regression was used to
examine the association between diurnal type continuous score (quantified as a z-score, i.e.
mean of 0 and standard deviation of 1) and continuous ND measurements and cotinine
values. To test the linearity of the association, higher order polynomials (quadratic and
cubic) of diurnal score were also fit to the regression model. Multinomial logit modeling
was used to examine the association between diurnal type category and categorical time to
first cigarette (TTF, single item of FTND scale) variable. Interaction of diurnal type and sex
was also tested (nested models likelihood), and where significant, sex-specific analyses are
reported. All models were adjusted for age and sex. Further adjustment for alcohol use and
depression were used to test whether the association between diurnal type and ND was
independent of alcohol use and depression. The data analyses were performed with Stata
(version 11) statistical software [30].
Results
FINRISK sample
The total number of participants with both diurnal type and smoking status information was
7091 (Table 1). About 12% of individuals in FINRISK data were evening types and 48%
were morning types. The prevalence of current smokers (daily or occasional) was higher
among evening types (37%) than in morning types (22%) (Table 2). Similarly the proportion
of ever smokers (current or former) was larger in evening types (62%) than in morning types
(54%). Similar patterns were found among both men and women.
In order to assess any non-response bias we analyzed if missing data on diurnal type
depended on smoking status in FINRISK data. Information on diurnal type was missing in
about 10% of current smokers, 9% former smokers and 10% never smokers. The distribution
of smoking status did not differ between those with and without diurnal type (age-sex
adjusted logistic regression p-value=0.38).
In this study sample about six per cent of men used 24 or more alcoholic drinks and two
percent of women used 16 or more drinks per week. Twenty six per cent of men and 42% of
women used no alcohol during previous week. The average use was 7.9 (10.4 SD) drinks per
week in men and 3.2 (6.2 SD) drinks in women. About 14% of participants (11% of men
and 16 % of women) had depressive symptoms by two screening questions.
Logistic regression analyses of smoking status and diurnal type
Risk for being a current smoker (vs. non-smoker) (n=7091) and ever smoker (vs. never
smoker) (n=7091) for evening types compared to morning types was analyzed by logistic
regression. These analyses were adjusted for age and sex and in addition in separate models
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for alcohol use and depressive symptoms (Table 3). The odds ratio (OR) of being a current
smoker among evening types was 1.66 (95% CI 1.40, 1.97) compared to morning types. No
gender by diurnal interaction was found (p=0.79).
Results remained significant although the effect size decreased marginally when adjusted for
alcohol use (OR=1.51, 95% CI 1.26, 1.80). The association weakened a bit more when
adjusted for depression (OR=1.45, 95% CI 1.22, 1.73). Further attenuation was observed
when adjusted simultaneously for both potential confounders (OR=1.35, 95% CI 1.12, 1.61),
but the association remained significant (Table 3). Relatively small changes in risk estimates
among current smokers indicated that alcohol use and depressive symptoms did not account
for the association of diurnal type with current smoking.
The OR of being ever smoker among evening types was 1.42 (95% CI 1.20, 1.67) times
higher compared to morning types (Table 3). There was a significant (p=0.01) gender by
diurnal type interaction for ever-smoking and gender-specific analyses were performed.
Among men age adjusted OR of being an ever smoker among evening types was 1.34 (95%
CI 1.03, 1.74) and among women 1.51 (95% CI 1.22, 1.86). The OR became non-significant
among men when adjusted for alcohol use and depression indicating that among men the
association between diurnal type and ever smoking is not fully independent of those
confounders.
DILGOM subsample of the FINRISK study
In the DILGOM subsample 13% were evening types and 47% morning types. We assessed
the representativeness of the DILGOM subset by comparing the risk of being a current
smoker by diurnal type in the total FINRISK sample and the DILGOM subset. As never
smokers were not present (by design) in DILGOM data, we computed logistic regression
analyses having current vs. former smoker as outcome variable in both data sets. The age
and sex adjusted OR of being a current smoker among evening types compared to morning
types in FINRISK data was 1.59 (95% CI 1.29, 2.00) and in DILGOM data 1.42 (95% CI
1.02, 1.20).
In DILGOM data three ND measurements, the FTND, the HONC, and the NDSS were used.
In addition plasma cotinine levels, reflecting nicotine intake, were measured among current
smokers. Descriptive statistics by diurnal type are given in Table 4 for current and former
smokers. The correlation between FTND and HONC was 0.56, between FTND and NDSS
0.69, and between HONC and NDSS 0.57. Among current smokers the correlations between
cotinine and FTND (r= 0.55), HONC (0.32) and NDSS (0.45) were more modest.
We used linear regression to examine the association between diurnal type score (continuous
variable z-score) and ND measurements (in ever smokers) and cotinine (square root
transformation to normalize the distribution) among current smoking participants (Table 5).
Significant gender by diurnal interactions for FTND (p=0.04) and cotinine (p=0.008) were
found but not for HONC (p=0.25) or NDSS (p=0.88). To test the linearity of the association,
we added quadratic and cubic terms for diurnal type score, but these higher order models did
not result in a significant improvement in model fit (likelihood ratio test), suggesting that
simple linear models fitted best to the data.
Linear regression showed significant association for diurnal type and FTND only in men
whereas for diurnal type and HONC significant association was seen for sexes combined.
Associations remained significant even after adjustment for alcohol use and depression.
When analyzing NDSS as dependent variable a significant association with diurnal type was
seen that remained after adjustment for alcohol use but further adjustment for depression
attenuated this association significantly (Table 5).
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Using cut-point of 4 or more on the FTND 40% of current smokers were ND (mean 3.0, SD
2.6). Among current smokers 48% of evening types were nicotine dependent compared to
40% of intermediate types and 38% of morning types. The age and sex adjusted OR of being
dependent on nicotine among evening types measured by FTND (≥4) was 1.82 (95% CI
1.18, 2.83). Adjusting for both alcohol use and depressive symptoms the risk among evening
types was attenuated but remained significant 1.59 (95% CI 1.01, 2.51).
Cotinine levels were highest among evening type group of current smokers (Table 4), and a
significant sex by diurnal type interaction was seen in the linear regression model. The
association was significant only among men remaining significant after adjustment for
alcohol use and depression (Table 5).
To help assess the relative impact of diurnal type on different measures of ND, effect sizes
with standardized linear regression coeffcients were computed (ND was dependent while
diurnal type was independent variable, adjusted for age and sex). Standardized estimates
indicated rather similar effect sizes of all ND measurements and nicotine intake, the FTND
(0.12), the HONC (0.11), the NDSS (0.14) and cotinine (0.10).
As one of the FTND scale’s six items, the TTF is showed to be a predictor of smoking
cessation [31], relapse [32] and is associated with higher cotinine levels [33] we examined
item of this scale among morning and evening type groups. Sixteen per cent of evening
types light up cigarette within 5 minutes after waking, compared to 8% of morning types.
Based on multinominal regression the OR of lighting up first cigarette in the morning within
first five minutes among evening types was three times (OR=2.95, 95% CI 1.74, 4.98)
higher compared to morning types. The risk decreased slightly when alcohol use (OR=2.82,
95% CI 1.66, 4.78), depression (OR=2.33, 95% CI 1.35, 4.01) and both confounders
together (OR=2.25, 95% CI 1.31, 3.89) were included into the analyses, but remained
elevated and highly significant. This indicates that alcohol use and depression did not
account for the association between diurnal type and TTF.
Discussion
Evening type is associated with daily smoking and ever smoking, higher scores on ND
measured by FTND, HONC and NDSS and plasma cotinine levels compared to morning
types. Association between evening type and smoking has been reported earlier [3,4,6,34] as
well as association between evening type and ND measured by number of DSM-IV
symptoms and FTND [7].
Associations of evening type with current and ever smoking remained after adjustment for
two potential confounders, alcohol use and presence of depressive symptoms during past
year. Adjustment for alcohol use and depression did not change results except that
depression attenuated the association of diurnal type with NDSS.
About 12% of individuals were evening types and 48% were morning types. An earlier
study found that 10% of participants to be clearly evening persons and 30% to be clearly
morning persons [7]. In the present study, diurnal type was measured with a six-item sum
scale derived from the Horne-Ostberg Morningness-eveningness questionnaire [24]. Earlier
Finnish studies [2,6,7] have measured this behavioral trait with a single question with four
alternative responses derived from the Torsvall-Akerstedt Diurnal type scale [35], yielding
no information about the intermediate types. Nonetheless the current study and the study on
Finnish adult twins show similar proportions of evening types.
Diurnal type is biologically determined but environmentally modified, about half of its
variation being explained by genetic effects [2,36]. This behavioural trait reflects the
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function of the circadian pacemaker that generates both the circadian rhythms and the
seasonal variations in mood and behavior [37] and interacts with the homeostatic sleep
process to produce the sleep-wake cycle. Concerning smoking behavior, nicotine is a direct
agonist of nAChRs and activates mesolimbic dopaminergic pathways [17]. In this reward
circuit, activation of the enzyme monoamine oxidase A is regulated by the circadian
pacemaker and Period 2 gene (PER2) abundance stimulates the transcription, leading to
reduced levels of dopamine and a predisposition to depressive-like behaviours [38,39], and
this compromises the feedback [40-42]. It is of note that there is a link between the PER2
gene variants and higher levels of alcohol use through the glutaminergic system [13], and
glutaminergic receptor genes associate with smoking behaviour as well [43,44]. Nicotine is
also a psychoactive stimulant, and this could make smokers more alert, delay the phase of
circadian rhythms and keep them staying up later. Clearly, there is a need for mechanistic
studies that analyze a biologically-based measure of diurnal type in relation to genetic data.
Diurnal type has been associated with anxiety [45], attention-deficit/hyperactivity disorder
(ADHD) [46] and depression [10,47-50], while depression is associated with a higher
prevalence of smoking [51,52]. In our earlier paper [7] mood and depression were assessed
with life satisfaction and the number of DSM-IV depression symptoms, and we found no
evidence that depression would confound the association between diurnal type and ND. In
the present study the adjustment for depression, based on two screening questions [29],
attenuated the strength and significance of the association. Mostly the association remained
highly significant, but the adjustment attenuated the association of diurnal type with NDSS.
This suggests that depression may confound the relationship between diurnal type and ND
measured with the NDSS. There may be a component of ND correlated with depression and
diurnal type captured by NDSS but not by other ND measures. This highlights the
importance of using multiple measures of ND as there is no single golden standard measure.
However, whether depression, instead of confounding, might actually mediate the
association between diurnal type and ND, remains a challenge of further research, because
mediation can be tested reliably only in a longitudinal design [53]. It is possible that
socioeconomic status (SES) could be associated to diurnal type. However, in present study
adjustment for SES did not diminish the strength and association as reported earlier [54].
ND measurements included the widely used FTND scale [8] which assesses physical
dependence and predicts relapses [55]. ND was also measured by the HONC identifying a
loss of autonomy in smoking [21]. In addition, the multidimensional NDSS was used
assessing drive, priority, continuity, stereotype and tolerance [22]. As linear regression
analysis with adjustment of depressive symptoms attenuated the association of diurnal type
with NDSS and not with FTND or HONC it seems that this multidimensional association
between ND and depression needs further examination. In the earlier study we used also
FTND and no attenuation was seen between diurnal type and FTND scale when adjusted for
number of DSM-IV symptoms of depression. FTND and HONC scales are unidimensional
whereas NDSS is multidimensional with physiological, psychological and social
dependency items, having five or less subscales depending on data [22].
The associations of FTND and cotinine levels with diurnal type showed similar patterns.
Both showed significant sex interactions, with stronger associations in men than in women.
A central element of FTND is amount smoked daily, which is also indexed by cotinine
levels [56]. The other central element of FTND is TTF, which together with amount smoked
accounts for some 80% of the variance in FTND, and the two together forms the Heaviness
of Smoking Index scale [57]. Moreover, we found that risk for evening types to light up the
first cigarette in the morning within five first minutes after waking was three times higher
compared to morning types. This could possibly be due to higher ND overall or worse
capability to tolerate decreased morning level of nicotine in circulation causing more severe
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physical withdrawal symptoms. Interestingly, a study of adult smokers in the UK indicated
that the first cigarette of the day and smoked cigarettes during the night are inhaled less
intensively [58]. Our earlier study shows [7] that heavy smoking (>20 cigarettes per day) is
associated with evening type. The present study is in line with that finding. The current
finding indicates that higher cotinine levels and higher FTND score (including cigarettes per
day item) are related to evening type. It is noteworthy that associations of evening type with
cotinine and FTND were significant only among men, possibly due to the fact that daily
cigarette consumption of men is higher.
FINRISK and DILGOM data have several strengths. FINRISK is a representative large
population-based sample collected in 2007 and thus represents well the existing smoking
prevalence in Finland. Also the DILGOM subsample appears to represent the population
well as the association of diurnal type and smoking status was similar to that in the whole
dataset. An additional strength is that study applied multiple ND measures and cotinine
levels derived from population data.
The possible causality behind the observed association remains unknown as a cross-
sectional survey does not provide adequate design to determine causality for the association
between diurnal type and smoking. Follow-up data is needed in order to address this
question. Longitudinal studies are required to assess the changes and interdependencies in
diurnal type, smoking habits and ND. Also other types of studies are needed for example
observing the behavior, peer interaction and other substance use, alcohol and drugs, of
evening and morning types in adolescence, when smoking commonly is initiated. In
addition, as in our study the information on diurnal type is derived from a self-report, there
is a further need for studies that use a biologically-based measure of diurnal type or that of
rest-activity cycle for assessment.
The results observed in the older Finnish Twin Cohort data were replicated and extended.
This study further supports earlier finding, that evening type is an important determinant of
ND and associated with multiple ND measures and nicotine intake. Evening type persons
are at higher risk of dependence, although depressive symptoms to some extent attenuate
this risk. Understanding the factors underlying the associations between chronotype and ND
could provide novel insights into the mechanisms of nicotine addiction.
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Table 2
Proportion (%) of current (=daily and occasional) and ever (=current and former) smokers by diurnal type in
FINRISK data (n=7091) among all participants and by sex.
All Men Women
Current smokers
Morning type 22.1 26.3 17.9
Intermediate type 24.1 29.5 20.1
Evening type 36.9 44.9 31.3
n=7091 n=3264 n=3827
Ever smokers
Morning type 53.7 65.7 42.0
Intermediate type 52.1 62.0 44.7
Evening type 62.1 70.1 56.5
n=7091 n=3264 n=3827
J Addict Res Ther. Author manuscript; available in PMC 2012 August 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Broms et al. Page 16
Ta
bl
e 
3
Lo
gi
sti
c 
re
gr
es
sio
n 
od
ds
 ra
tio
s (
an
d 9
5 %
 co
nfi
de
nc
e i
nte
rva
ls)
 fo
r r
isk
 of
 be
ing
 cu
rre
nt 
sm
ok
er 
(vs
.
 
n
o
n
-s
m
o
ke
r) 
an
d e
ve
r s
mo
ke
r (
v
s.
 
n
ev
er
 s
m
o
ke
r) 
in
FI
N
RI
SK
 d
at
a 
am
on
g 
ev
en
in
g 
ty
pe
s c
om
pa
re
d 
to
 m
or
ni
ng
 ty
pe
s. 
Ea
ch
 ro
w
 sh
ow
s t
he
 v
ar
ia
bl
es
 in
cl
ud
ed
 in
 th
e 
m
od
el
. A
ge
 is
 in
cl
ud
ed
 in
 a
ll 
m
od
el
s a
nd
se
x
 o
n
ly
 w
he
n 
m
en
 a
nd
 w
om
en
 w
er
e 
an
al
yz
ed
 to
ge
th
er
.
Ev
en
in
g 
ty
pe
 v
s.
 
M
or
ni
ng
 ty
pe
O
R
 fo
r C
ur
re
nt
 sm
ok
in
g 
vs
.
 
N
on
-s
m
ok
in
g
O
R
 fo
r E
ve
r s
m
ok
in
g 
vs
.
 
N
ev
er
 sm
ok
in
g
M
od
el
s a
dju
ste
d f
or
:
A
ll
M
en
W
om
en
A
ll
M
en
W
om
en
A
ge
 a
nd
 se
x
1.
66
 (1
.40
, 1
.97
)
1.
68
 (1
.31
, 2
.16
)
1.
65
 (1
.30
, 2
.09
)
1.
42
 (1
.20
, 1
.67
)
1.
34
 (1
.03
, 1
.74
)
1.
51
 (1
.22
, 1
.86
)
A
lc
oh
ol
 u
se
a
1.
51
 (1
.26
 1.
80
)
1.
54
 (1
.19
,1.
99
)
1.
42
 (1
.11
, 1
.82
)
1.
31
 (1
.11
, 1
.55
)
1.
25
 (0
.96
, 1
.63
)
1.
35
 (1
.10
, 1
.67
)
D
ep
re
ss
io
nb
1.
45
 (1
.22
, 1
.73
)
1.
47
 (1
.33
, 1
.90
)
1.
44
 (1
.13
, 1
.83
)
1.
28
 (1
.08
, 1
.51
)
1.
18
 (0
.91
, 1
.54
)
1.
38
 (1
.12
, 1
.71
)
A
lc
oh
ol
 u
se
 a
nd
 d
ep
re
ss
io
n
1.
35
 (1
.12
, 1
.61
)
1.
38
 (1
.06
, 1
.80
)
1.
27
 (1
.00
, 1
.63
)
1.
20
 (1
.02
, 1
.42
)
1.
12
 (0
.86
, 1
.47
)
1.
26
 (1
.01
, 1
.56
)
a G
ra
m
s /
 w
ee
k 
(co
nti
nu
ou
s v
ari
ab
le)
b T
w
o 
sc
re
en
in
g 
qu
es
tio
ns
: P
os
iti
ve
 re
sp
on
se
 to
 tw
o 
br
ie
f i
te
m
s o
f d
ep
re
ss
io
n 
(pr
ese
nc
e f
or 
tw
o w
ee
ks
 du
rin
g p
ast
 ye
ar 
de
pre
sse
d m
oo
d a
nd
 / o
r a
nh
ed
on
ia)
 (v
ari
ab
le 
of 
thr
ee
 ca
teg
ori
es)
J Addict Res Ther. Author manuscript; available in PMC 2012 August 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Broms et al. Page 17
Ta
bl
e 
4
M
ea
ns
 (a
nd
 st
an
da
rd 
de
via
tio
ns
) o
f t
he
 FT
ND
, th
e H
ON
C,
 th
e N
DS
S a
nd
 pl
asm
a c
oti
nin
e l
ev
els
 (μ
g/
L)
 (c
oti
nin
e i
nfo
rm
ati
on
 av
ail
ab
le 
on
ly 
on
 cu
rre
nt
sm
o
ke
rs
) i
n t
hre
e d
iur
na
l ty
pe
 gr
ou
ps
 am
on
g c
urr
en
t s
mo
ke
rs 
(n=
71
2) 
an
d f
orm
er 
sm
ok
ers
 (n
=6
33
) i
n D
IL
GO
M
 su
b-s
am
ple
 of
 th
e F
IN
RI
SK
 st
ud
y.
FT
N
D
 M
ea
n 
(S
D)
H
O
N
C
 M
ea
n 
(S
D)
N
D
SS
 M
ea
n 
(S
D)
C
ot
in
in
e (
μg
/L
) M
ea
n (
SD
)
C
ur
re
nt
 sm
ok
er
s
M
or
ni
ng
 ty
pe
3.
04
 (2
.42
)
5.
24
 (2
.92
)
17
.2
 (7
.44
)
14
6 
(97
.3)
In
te
rm
ed
ia
te
 ty
pe
2.
84
 (2
.55
)
5.
41
 (2
.89
)
16
.6
 (8
.44
)
14
4 
(97
.9)
Ev
en
in
g 
ty
pe
3.
54
 (3
.00
)
5.
98
 (3
.08
)
19
.3
 (1
0.4
3)
16
1 
(10
7)
Fo
rm
er
 sm
ok
er
s
M
or
ni
ng
 ty
pe
2.
13
 (2
.26
)
3.
49
 (2
.87
)
16
.8
 (7
.69
)
n
.a
.*
In
te
rm
ed
ia
te
 ty
pe
2.
04
 (2
.20
)
3.
69
 (2
.93
)
16
.8
 (8
.02
)
n
.a
.
Ev
en
in
g 
ty
pe
2.
64
 (2
.76
)
4.
48
 (3
.29
)
19
.1
 (9
.80
)
n
.a
.
*
Co
tin
in
e 
in
fo
rm
at
io
n 
av
ai
la
bl
e 
on
ly
 o
n 
cu
rre
nt
 sm
ok
er
s
FT
N
D
=t
he
 F
ag
er
str
öm
 T
es
t f
or
 N
ic
ot
in
e 
D
ep
en
de
nc
e,
 H
O
N
C=
th
e 
H
oo
ke
d 
on
 N
ic
ot
in
e 
Ch
ec
kl
ist
, N
D
SS
=t
he
 N
ic
ot
in
e 
D
ep
en
de
nc
e 
Sy
nd
ro
m
e 
Sc
al
e
J Addict Res Ther. Author manuscript; available in PMC 2012 August 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Broms et al. Page 18
Ta
bl
e 
5
Li
ne
ar
 re
gr
es
sio
n 
an
al
ys
is 
(be
ta-
co
eff
ici
en
t a
nd
 95
% 
co
nfi
de
nc
e i
nte
rva
ls)
 of
 th
e F
ag
ers
tro
m 
Te
st 
for
 N
ico
tin
e D
ep
en
de
nc
e (
FT
ND
, n
=7
12
), t
he
 H
oo
ke
d
o
n
 N
ic
ot
in
e 
Ch
ec
kl
ist
 (H
ON
C,
 n=
78
1),
 th
e N
ico
tin
e D
ep
en
de
nc
e S
yn
dro
me
 Sc
ale
 (N
DS
S, 
n=
78
1) 
an
d c
oti
nin
e (
n=
64
5) 
wi
th 
res
pe
ct 
to 
diu
rna
l s
co
re
(co
nti
nu
ou
s v
ari
ab
le 
z-s
co
re)
 am
on
g c
urr
en
t s
mo
kin
g p
art
ici
pa
nts
 in
 D
IL
GO
M
 da
ta.
D
iu
rn
al
 ty
pe
 a
dju
ste
d
FT
N
D
H
O
N
C
*
N
D
SS
*
C
ot
in
in
e
M
en
W
om
en
M
en
W
om
en
A
ge
 (s
ex
*
) -
-
0.
46
 (-
0.7
2, 
-0.
21
)
-
0.
02
 (-
0.2
7, 
0.2
5)
-
0.
31
 (-
0.5
2, 
-0.
11
)
-
0.
86
 (-
1.4
3, 
-0.
29
)
-
0.
73
 (-
1.1
6, 
-0.
29
)
0.
11
 (-
0.3
6, 
0.5
9)
A
ge
 (s
ex
), A
lco
ho
l u
sea
-
0.
46
 (-
0.7
2, 
-0.
20
)
-
0.
00
2 
(-0
.26
, 0
.26
)
-
0.
30
 (-
0.5
0, 
-0.
10
)
-
0.
79
 (-
1.3
7, 
-0.
21
)
-
0.
75
 (-
1.1
9, 
-0.
32
)
0.
11
 (-
0.3
7, 
0.5
9)
A
ge
 (s
ex
), D
ep
res
sio
nb
-
0.
37
 (-
0.6
2, 
-0.
11
)
0.
06
 (-
0.1
9, 
0.3
1)
-
0.
21
 (-
0.4
2, 
-0.
01
)
-
0.
55
 (-
1.1
2, 
0.0
2) 
-
-
0.
67
 (-
1.1
1, 
-0.
22
)
0.
09
 (-
0.3
8, 
0.5
7)
A
ge
 (s
ex
), A
lco
ho
l u
se,
 de
pre
ssi
on
-
0.
37
 (-
0.6
3, 
-0.
12
)
0.
06
 (-
0.1
9, 
0.3
2)
-
0.
21
 (-
0.4
1, 
0.0
02
)
-
0.
50
 (-
1.0
7, 
0.0
8)
-
0.
69
 (-
1.1
4, 
-0.
24
)
0.
09
 (-
0.3
9, 
0.5
7)
*
Se
x 
w
as
 a
dju
ste
d w
he
n t
he
 H
ON
C 
an
d t
he
 N
DS
S s
cal
es 
we
re 
an
aly
zed
 du
e t
o n
o s
ign
ific
an
t in
ter
act
ion
s b
y s
ex
.
a G
ra
m
s /
 w
ee
k 
(co
nti
nu
ou
s v
ari
ab
le)
b T
w
o 
sc
re
en
in
g 
qu
es
tio
ns
: P
os
iti
ve
 re
sp
on
se
 to
 tw
o 
br
ie
f i
te
m
s o
f d
ep
re
ss
io
n 
(pr
ese
nc
e f
or 
tw
o w
ee
ks
 du
rin
g p
ast
 ye
ar 
de
pre
sse
d m
oo
d a
nd
 / o
r a
nh
ed
on
ia)
 (v
ari
ab
le 
of 
thr
ee
 ca
teg
ori
es)
J Addict Res Ther. Author manuscript; available in PMC 2012 August 17.
